Vanessa Carle is a Principal at Forbion, specializing in life sciences venture capital. Previously, they served as a Postdoctoral Researcher at EPFL, where they led a project focused on developing a novel anticoagulation therapy. Vanessa has also worked as an Associate at PharmaVentures, providing consultancy in pharma partnering and transaction-focused strategy. They hold a PhD in Chemical Biology and Drug Discovery from EPFL, along with a Master’s in Pharmaceutical Biotechnology from Martin-Luther-Universität Halle-Wittenberg. Additionally, Vanessa has experience in various board observer roles with emerging biotech companies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices